Le Lézard
Classified in: Science and technology
Subject: ATY

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Pivotal Software, Inc. has obtained a Fair Price in its sale to VMware, Inc.


MILWAUKEE, Aug. 22, 2019 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating Pivotal (NYSE: PVTL) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Pivotal to VMware.

Click here to learn how to join the action: http://ademilaw.com/case/pivotal-software-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi & O'Reilly, LLP alleges Pivotal's financial outlook is improving and yet shareholders will receive only $15 for each share of Pivotal common stock they own.  VMware is acquiring Pivotal at a substantial discount.  The merger agreement unreasonably limits competing bids for Pivotal by prohibiting solicitation of further bids, and imposing a termination penalty if Pivotal accepts a superior bid. Pivotal insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of Pivotal's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Pivotal.

If you own common stock in Pivotal and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://ademilaw.com/case/pivotal-software-inc.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi & O'Reilly, LLP


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: